Frontiers in Pharmacology | Pharmacogenetics and Pharmacogenomics

Mini Review

Published on 15 Nov 2022

Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure

in Pharmacogenetics and Pharmacogenomics

Jasmine M. Olvany
Scott M. Williams
Peter A. Zimmerman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.752314

2,509 views
2 citations

Editorial

Published on 11 Nov 2022

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs

in Pharmacogenetics and Pharmacogenomics

Wojciech Miltyk
George P. Patrinos
Celine Verstuyft
Marieke Coenen
Alireza Tafazoli

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053027

1,731 views

Editorial

Published on 11 Nov 2022

Editorial: Pharmacogenomics in neglected populations

in Pharmacogenetics and Pharmacogenomics

Mariana R. Botton
Jorge Duconge
Fernanda Rodrigues-Soares

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1081117

1,775 views
2 citations

Editorial

Published on 10 Nov 2022

Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?

in Pharmacogenetics and Pharmacogenomics

Abdeslam Jaafari
Subramani Srinivasan
Mounir Tilaoui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1067022

1,803 views

Original Research

Published on 09 Nov 2022

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

in Pharmacogenetics and Pharmacogenomics

Evelien G. E. Hurkmans
Jan B. Koenderink
Jeroen J. M. W. van den Heuvel
Yvonne M. H. Versleijen-Jonkers
Melissa H. S. Hillebrandt-Roeffen
Johanne M. Groothuismink
Hanneke I. Vos
Winette T. A. van der Graaf
Uta Flucke
Grigor Muradjan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1042989

3,205 views
3 citations

Review

Published on 04 Nov 2022

Relationship between miRNA and ferroptosis in tumors

in Pharmacogenetics and Pharmacogenomics

Shang-Ming Dai
Feng-Jiao Li
Hui-Zhi Long
Zi-Wei Zhou
Hong-Yu Luo
Shuo-Guo Xu
Li-Chen Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.977062

5,370 views
31 citations

Original Research

Published on 28 Oct 2022

Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant

in Pharmacogenetics and Pharmacogenomics

Mariam R. Habil
Mark A. Doll
David W. Hein

Frontiers in Pharmacology

doi 10.3389/fphar.2022.931323

1,895 views
2 citations

Original Research

Published on 26 Oct 2022

The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients

in Pharmacogenetics and Pharmacogenomics

Kenneth Chappell
Abd El Kader Ait Tayeb
Romain Colle
Jérôme Bouligand
Khalil El-Asmar
Florence Gressier
Séverine Trabado
Denis Joseph David
Bruno Feve
Laurent Becquemont

Frontiers in Pharmacology

doi 10.3389/fphar.2022.974570

2,043 views
7 citations

Original Research

Published on 24 Oct 2022

Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan

in Pharmacogenetics and Pharmacogenomics

Jan Grzegorzewski
Janosch Brandhorst
Matthias König

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1029073

5,148 views
6 citations

Original Research

Published on 14 Oct 2022

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis

in Pharmacogenetics and Pharmacogenomics

Kohei Ninomiya
Takeo Saito
Masashi Ikeda
Nakao Iwata
François R. Girardin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1016669

2,803 views
4 citations

Original Research

Published on 07 Oct 2022

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention

in Pharmacogenetics and Pharmacogenomics

Lida Chen
Chao Zheng
Mengmeng Hao
Peng Gao
Meimei Zhao
Yongtong Cao
Liang Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2022.889473

2,059 views
4 citations

Original Research

Published on 05 Oct 2022

Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2

in Pharmacogenetics and Pharmacogenomics

Mayara J. Prado
Rodrigo Ligabue-Braun
Arnaldo Zaha
Maria Lucia Rosa Rossetti
Amit V. Pandey

Frontiers in Pharmacology

doi 10.3389/fphar.2022.931089

4,027 views
5 citations

Original Research

Published on 03 Oct 2022

Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder

in Pharmacogenetics and Pharmacogenomics

Caroline W. Grant
Angelina R. Wilton
Rima Kaddurah-Daouk
Michelle Skime
Joanna Biernacka
Taryn Mayes
Thomas Carmody
Liewei Wang
Konstantinos Lazaridis
Richard Weinshilboum

Frontiers in Pharmacology

doi 10.3389/fphar.2022.984383

5,529 views
7 citations

Opinion

Published on 26 Sep 2022

Pharmacogenomics at the post-pandemic: If not now, then when?

in Pharmacogenetics and Pharmacogenomics

Zeina N. Al-Mahayri

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1013527

1,846 views

Original Research

Published on 23 Sep 2022

A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients

in Pharmacogenetics and Pharmacogenomics

Innocent G. Asiimwe
Marc Blockman
Karen Cohen
Clint Cupido
Claire Hutchinson
Barry Jacobson
Mohammed Lamorde
Jennie Morgan
Johannes P. Mouton
Doreen Nakagaayi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.967082

4,619 views
11 citations

Original Research

Published on 23 Sep 2022

TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned

in Pharmacogenetics and Pharmacogenomics

Liuh Ling Goh
Chia Wei Lim
Khai Pang Leong
Kiat Hoe Ong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.837164

8,926 views
11 citations

Navigation group

Articles

Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs

Editorial: Pharmacogenomics in neglected populations

Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

Relationship between miRNA and ferroptosis in tumors

Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant

The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients

Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention

Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2

Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder

Pharmacogenomics at the post-pandemic: If not now, then when?

A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients

TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned